Senior BiostatisticianLFB-USAFramingham, Massachusetts, United States
PB0693 - Efficacy and Safety of Eptacog Beta (Recombinant Activated FVII) in Patients with Hemophilia A or B with Inhibitors According to Time to Initial Infusion: a Post-Hoc Analysis from PERSEPT-1
Monday, June 26, 202318:30 – 19:30 ET
